1. Au, H.-J., Ringash, J., Brundage, M. D., Palmer, M., Richardson, H., & Meyer, R. M. (2010). Added value of health-related quality of life measurement in cancer clinical trials: A review of the experience of the NCIC CTG. Expert Review of Pharmacoeconomics & Outcomes Research, 10(2), 119–128.
2. Till, J. E., Osoba, D., Pater, J. L., & Young, J. R. (1994). Research on health-related quality of life: Dissemination into practical applications. Quality of Life Research, 3(4), 279–283.
3. Osoba, D. (2005). The clinical value and meaning of health-related quality-of-life outcomes in oncology. In J. Lipscomb, C. C. Gotay, & C. Snyder (Eds.), Outcomes assessment in cancer (1st ed., pp. 386–405). Cambridge: Cambridge University Press.
4. Schwartz, C. E., & Sprangers, M. A. G. (2002). An introduction to quality of life assessment in oncology: The value of measuring patient-reported outcomes. American Journal of Management Care, 8(18 Suppl), S550–S559.
5. Lipscomb, J., Reeve, B. B., Clauser, S. B., et al. (2007). Patient-reported outcomes assessment in cancer trials: Taking stock, moving forward. Journal of Clinical Oncology, 25(32), 5133–5140.